http://www.tase.co.il/TASEEng/General/Company/companyMainData.htm?subDataType=0&companyID=001272
Thats based on a share price of 33.80 and 273,379,902 shares outstanding
but if I do the math it 33.8 x 94.6M it comes off by a factor of roughly 10 (924,024,0687.6). Can someone help me understand what I'm missing?
If I look at the ADR being a 50-a ratio that would mean roughly 5.5M shares (in US ADR terms) at a price of roughly 5 would be a market cap of 27.5M.
If I then use an exchange of 3.75 Shekel to a dollars its roughly 100M shekel which is roughly consistent to what the TASE website shows.
Appreciate any clarifications anyone can give. TIA!
Recent CANF News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:09:46 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/17/2026 11:50:36 AM
- Can-Fite Expands Namodenoson anti-Obesity Franchise with Israeli Patent Allowance • GlobeNewswire Inc. • 03/17/2026 11:47:08 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/10/2026 08:30:01 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/05/2026 12:31:41 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/05/2026 12:29:04 PM
- Can-Fite Announces Exercise of Warrants for Approximately $4.0 Million in Gross Proceeds • GlobeNewswire Inc. • 03/04/2026 03:25:41 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/04/2026 12:05:05 PM
- Can-Fite’s Namodenoson Successfully Meets Primary Endpoint in Phase 2a Pancreatic Cancer Study • GlobeNewswire Inc. • 03/04/2026 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/17/2026 12:01:59 PM
- Can-Fite Announces Scientific Breakthrough Publication Demonstrating Anti-Obesity Effect of Namodenoson • GlobeNewswire Inc. • 02/17/2026 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/09/2026 12:12:14 PM
- Can-Fite: Receives Canadian Patent Allowance for Namodenoson as an Anti-Obesity Therapy • GlobeNewswire Inc. • 02/09/2026 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/05/2026 12:03:25 PM
- Can-Fite: Patient with Decompensated Liver Cirrhosis Successfully Undergoes Liver Transplantation Following Treatment with Namodenoson • GlobeNewswire Inc. • 02/05/2026 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/27/2026 09:15:30 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/20/2026 12:01:37 PM
- Can-Fite Completes Patient Enrollment in Phase 2a Pancreatic Cancer Study of Namodenoson • GlobeNewswire Inc. • 01/20/2026 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/16/2026 09:15:25 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/29/2025 11:03:50 AM
- This Microcap Just Locked Up New IP in a Massive Pharma Market • AllPennyStocks.com • 12/26/2025 03:28:00 PM
- Can-Fite Granted Brazilian Patent for Treatment of Sexual Dysfunction • GlobeNewswire Inc. • 12/26/2025 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/23/2025 09:50:12 PM
- Can-Fite Announces Reverse Split of its Ordinary Shares and ADS Ratio Change • GlobeNewswire Inc. • 12/23/2025 09:46:25 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/16/2025 02:21:05 PM
Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • BLOZF • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
